Hansa Biopharma saw the highest growth of 0.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Hansa Biopharma’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Hansa Biopharma has been focused on protecting inventions in Australia(AU) with one publication in Q2 2024
The Australia(AU) Patent Office dominates the patent filings with nearly 33% of filings. The Australia(AU), European Patent Office(EPO), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Hansa Biopharma is filings its patents..
Roche and Johnson & Johnson could be the strongest competitors for Hansa Biopharma
Patents related to cell & gene therapy and immuno-oncology lead Hansa Biopharma's portfolio
Hansa Biopharma has the highest number of patents in cell & gene therapy followed by, immuno-oncology and rare diseases. For cell & gene therapy, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Cyst related patents lead Hansa Biopharma portfolio
Hansa Biopharma has highest number of patents in cyst.
For comprehensive analysis of Hansa Biopharma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
